BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29805638)

  • 1. PRL-3 promotes gastric cancer peritoneal metastasis via the PI3K/AKT signaling pathway
    Zhang Y; Li Z; Fan X; Xiong J; Zhang G; Luo X; Li K; Jie Z; Cao Y; Huang Z; Wu F; Xiao L; Duan G; Chen H
    Oncol Lett; 2018 Jun; 15(6):9069-9074. PubMed ID: 29805638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.
    Xiong J; Li Z; Zhang Y; Li D; Zhang G; Luo X; Jie Z; Liu Y; Cao Y; Le Z; Tan S; Zou W; Gong P; Qiu L; Li Y; Wang H; Chen H
    Oncol Rep; 2016 Oct; 36(4):1819-28. PubMed ID: 27572739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1 and PI3K/Akt signaling blockers DAPT and LY294002 coordinately inhibit metastasis of gastric cancer through mutual enhancement.
    Peng X; Zhou J; Li B; Zhang T; Zuo Y; Gu X
    Cancer Chemother Pharmacol; 2020 Feb; 85(2):309-320. PubMed ID: 31732769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DJ-1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway.
    Zhu ZM; Li ZR; Huang Y; Yu HH; Huang XS; Yan YF; Shao JH; Chen HP
    Oncol Rep; 2014 Mar; 31(3):1489-97. PubMed ID: 24398929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis.
    Li Z; Zhan W; Wang Z; Zhu B; He Y; Peng J; Cai S; Ma J
    Biochem Biophys Res Commun; 2006 Sep; 348(1):229-37. PubMed ID: 16875667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
    Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
    Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
    Gao P; Wang S; Jing F; Zhan J; Wang Y
    Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.
    Zhang XB; Song L; Wen HJ; Bai XX; Li ZJ; Ma LJ
    Tumour Biol; 2016 Jun; 37(6):8317-25. PubMed ID: 26729197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
    Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine.
    Xie X; Tang B; Zhou J; Gao Q; Zhang P
    Oncol Rep; 2013 Aug; 30(2):773-82. PubMed ID: 23743572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERBB4 promotes the proliferation of gastric cancer cells via the PI3K/Akt signaling pathway.
    Xu J; Gong L; Qian Z; Song G; Liu J
    Oncol Rep; 2018 Jun; 39(6):2892-2898. PubMed ID: 29620274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dickkopf-related protein 1/cytoskeleton-associated protein 4 signaling activation by
    Luo M; Chen YJ; Xie Y; Wang QR; Xiang YN; Long NY; Yang WX; Zhao Y; Zhou JJ
    World J Gastroenterol; 2022 Dec; 28(47):6769-6787. PubMed ID: 36620343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-Regulation of Phosphatase in Regenerating Liver-3 (PRL-3) Contributes to Malignant Progression of Hepatocellular Carcinoma by Activating Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN)/Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway.
    Li BH; Wang Y; Wang CY; Zhao MJ; Deng T; Ren XQ
    Med Sci Monit; 2018 Nov; 24():8105-8114. PubMed ID: 30418964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer.
    Chen DL; Zeng ZL; Yang J; Ren C; Wang DS; Wu WJ; Xu RH
    J Hematol Oncol; 2013 Jun; 6():43. PubMed ID: 23806079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astaxanthin Inhibits Matrix Metalloproteinase Expression by Suppressing PI3K/AKT/mTOR Activation in
    Lee J; Lim JW; Kim H
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014933
    [No Abstract]   [Full Text] [Related]  

  • 17. PIAS1 inhibited the metastasis of gastric cancer cell by epithelial-mesenchymal transition regulation within the inflammatory microenvironment.
    Wang X; Wang L; Xu Y; Zhang G; Wu Y; Chen P
    Oncol Lett; 2018 Mar; 15(3):3828-3837. PubMed ID: 29556278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-associated silencing of miR-495 inhibit the migration and invasion of human gastric cancer cells by directly targeting PRL-3.
    Li Z; Zhang G; Li D; Jie Z; Chen H; Xiong J; Liu Y; Cao Y; Jiang M; Le Z; Tan S
    Biochem Biophys Res Commun; 2015 Jan; 456(1):344-50. PubMed ID: 25475733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells.
    Liang J; Ge F; Guo C; Luo G; Wang X; Han G; Zhang D; Wang J; Li K; Pan Y; Yao L; Yin Z; Guo X; Wu K; Ding J; Fan D
    FEBS J; 2009 Feb; 276(3):685-94. PubMed ID: 19143835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.